{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-326784","form_type":"8-K","ticker":"ACET","cik":"0001720580","company_name":"Adicet Bio, Inc.","filed_at":"2025-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.250215+00:00","generated_at":"2026-05-16T12:36:32.131295+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Adicet Bio stockholders approve reverse stock split (1:5 to 1:30)","bullets":["Proposal passed with 111,115,503 votes for, 2,752,862 against, and 117,502 abstentions.","Board will set exact split ratio within the approved range at its discretion.","Special meeting held on December 19, 2025; no other proposals were considered."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-326784","json":"https://secwatch.observer/filing/0001193125-25-326784.json","markdown":"https://secwatch.observer/filing/0001193125-25-326784.md","text":"https://secwatch.observer/filing/0001193125-25-326784.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1720580/000119312525326784/0001193125-25-326784-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1720580/000119312525326784/acet-20251219.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:36:32.131295+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}